๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results

โœ Scribed by C. C. Wang

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
558 KB
Volume
63
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Carcinoma of the nasopharynx. Eighteen y
Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy
โœ Richard T. Hoppe; Don R. Goffinet; Malcolm A. Bagshaw ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 561 KB

From 1956 through 1973, 82 patients with carcinoma of the nasopharynx received high dose megavoltage radiation therapy a t Stanford University. The actuarial disease-free (NED) survival was 62% a t 5 years and 56% a t 10 years. The NED survivals a t 5 years for patients with T I , T2, and T3 lesion

Long-term results of hyperfractionated r
Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma
โœ Paul M. Spring; Joseph Valentino; Susanne M. Arnold; David Sloan; Daniel Kenady; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB

## Abstract ## BACKGROUND In this report, the authors present the results from a study of patients with unresectable oropharyngeal squamous cell carcinomas who were treated on a protocol of hyperfractionated radiation and highโ€dose intraarterial cisplatin (HYPERRADPLAT) at the University of Kentuc

Final report of a phase I/II trial of hy
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02
โœ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho

interruptions adversely affect local con
interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313
โœ James D. Cox; Thomas F. Pajak; Victor A. Marcial; Lawrence Coia; Mohammed Mohiud ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 474 KB ๐Ÿ‘ 2 views

Hyperfractionated radiation therapy (HFX) attempts to overcome tumor proliferation during treatment by permitting higher total doses in the same overall time as standard fractionation. Whereas interruptions, including splits, reduce local control with standard fractionation in carcinoma of the upper